Journal
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
Volume 13, Issue 6, Pages 2049-2059Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.nano.2017.03.015
Keywords
Fullerene; Radiculopathy; DRG; Inflammasome; Hyperalgesia; Low back pain
Funding
- National Institutes of Health [RO1AR064792, R21AR057512]
- North American Spine Society
Ask authors/readers for more resources
The present study aimed to evaluate the analgesic effect of the antioxidant nanoparticle fullerol in a mouse radiculopathy and a dorsal root ganglion (DRG) culture models. Intervertebral disk degeneration causes significant hyperalgesia and nerve inflammation. Pain sensitization and inflammatory reaction were counteracted by fullerol when disk material was bathed in 10 or 100 mu M of fullerol prior to implantation. Immunohistochemistry showed similar massive IBA1 positive macrophage infiltration surrounding implanted disk material among groups, but IL-1 beta and IL-6 expression was decreased in the fullerol treated group. In the DRG explant culture, after treatment with TNF-alpha, the expression of IL-1 beta, NLRP3, and caspase 1 was significantly increased but this was reversed by the addition of fullerol. In addition, fullerol also decreased the expression of substance P and CGRP in the cultured DRGs. Nanoparticle fullerol effectively counteracts pain sensitization and the inflammatory cascade caused by disk degeneration. (C) 2017 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available